{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-000968","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.999097+00:00","generated_at":"2026-05-16T11:48:02.453519+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eledon exchanges 4.2M shares for pre-funded warrant with Coastlands","bullets":["Exchange of 4,203,764 common shares for pre-funded warrant at $0.001 exercise price.","Warrant has 4.99% beneficial ownership limitation, can be increased to 19.99% per Nasdaq rules.","Issued under Section 3(a)(9) exemption; exchange closed December 30, 2025.","Counterparty: Coastlands Capital Partners LP."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-000968","json":"https://secwatch.observer/filing/0001193125-26-000968.json","markdown":"https://secwatch.observer/filing/0001193125-26-000968.md","text":"https://secwatch.observer/filing/0001193125-26-000968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526000968/0001193125-26-000968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526000968/eldn-20251230.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:48:02.453519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}